Grant Application


GLA is now accepting grant proposals for its 2018-19 funding cycle. All applications are due by August 1, 2018 midnight EST. Award decisions will be announced in January 2019.

Global Lyme Alliance encourages proposals for the 2018-19 Research Grant Award Program that explore regulation of Lyme disease and other tick-borne disease pathogenesis, with an emphasis on the role of an individual’s microbiome as well as genetic and epigenetic factors that might inform a “personalized medicine” approach to treatment. Proposals in other topical areas related to Lyme and other tick-borne diseases also will be accepted. Small-scale grants for proof-of-concept studies lasting one year, can be requested for between $50,000 and $100,000. Full-scale grants may request larger amounts, up to $175,000 per year to be spent over the course of a two to three-year period of funding. Clearly defined milestones will be required for both one year and multi-year proposals.

click here


Grants are reviewed by the Grant Review Committee (GRC) of the Scientific Advisory Board (SAB), composed of experts in the tick-borne diseases research field. The Financial Review Committee (FRC) is available to advise in the event of any conflicts of interest or for commercial applications. Applications are reviewed by GLA to assure completion before review by the SAB.


  • Significance or impact of the study to drive the science concerning Lyme and other tick-borne diseases forward
  • Expertise and previous rate of success of principal investigator and collaborators
  • Innovation supported by fact-based concepts and methods
  • Compatibility of the scope of work to the specific goals of the project/compatibility of the scope of work to the proposed budget
  • Appropriate scientific environment

Once the entire grant review process is completed, the committee meets to discuss and prioritize the grant application award list in conjunction with the monies available, as assigned by GLA’s Executive Committee. The GRC makes its recommendations to the GLA Board of Directors, who make final decisions following majority approval of these recommendations.

All grant recipients are required to sign a Research Grant Agreement, created to protect both the grant recipient(s) and GLA. These agreements are tailored to each individual grant and are subject to negotiation. Monies are only awarded to a medical institution, foundation, or university, never to an individual. GLA accepts up to 10% indirect costs.

Learn more
The Deborah and Mark Blackman-GLA postdoctoral fellowships in Borrelia persistence and host evasion.